Dinoprostone Use in Labor Induction Guidelines

Primary Indication and Contraindications

• Dinoprostone is indicated for cervical ripening in pregnant women at or near term with an unfavorable cervix when there is a medical or obstetrical indication for labor induction, provided there are no absolute contraindications, as recommended by the American College of Obstetricians and Gynecologists 1
• Active cardiovascular disease is an absolute contraindication due to profound blood pressure effects, theoretical risk of coronary vasospasm, and low but real risk of arrhythmias, according to the European Society of Cardiology 2

Special Populations and Administration

• Prostaglandin E2 has not been associated with worsening lung function or asthma exacerbation, and can be used with appropriate monitoring in patients with asthma, as stated by the American Thoracic Society 5
• High-risk patients should deliver in tertiary centers with specialist multidisciplinary team care, as recommended by the European Society of Cardiology 2

Dosing and Administration Protocol

• The dinoprostone insert releases approximately 0.3 mg/hour, and the maximum duration of use is 12 hours, as recommended by the American College of Obstetricians and Gynecologists 1
• Wait at least 30 minutes after removing dinoprostone before starting oxytocin, as recommended by the American College of Obstetricians and Gynecologists 1

Mandatory Monitoring Requirements

• Continuous monitoring is required throughout dinoprostone administration, including continuous fetal heart rate monitoring and continuous uterine activity monitoring, as recommended by the American College of Obstetricians and Gynecologists 1, 5

Comparison with Alternative Agents

• Oral misoprostol results in fewer cesarean sections (RR 0.84) and costs significantly less than dinoprostone, but is absolutely contraindicated in women with prior cesarean delivery, as stated by the American College of Obstetricians and Gynecologists 1, 3
• Mechanical methods are preferred in patients with active cardiovascular disease or prior cesarean delivery, as recommended by the European Society of Cardiology 2, 5

Common Pitfalls to Avoid

• Avoid prolonged induction time when cervix remains unfavorable, and consider alternative methods, as recommended by the European Society of Cardiology 4, 5
• Do not use dinoprostone in active cardiovascular disease, and choose mechanical methods instead, as recommended by the European Society of Cardiology 2, 3